Northwestern Mutual Wealth Management CO Travere Therapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 204 shares of TVTX stock, worth $4,222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
204Holding current value
$4,222% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.3MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$158 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$152 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$140 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$103 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$88.2 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.33B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...